Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.52 |
| ▸ | CA2 | P00918 | 9/20 | 0.52 |
| ▸ | CA9 | Q16790 | 8/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.52 |
| ▸ | CA3 | P07451 | 2/20 | 0.52 |
| ▸ | CA4 | P22748 | 2/20 | 0.52 |
| ▸ | CA6 | P23280 | 2/20 | 0.52 |
| ▸ | CA5A | P35218 | 2/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28172236 | 1.00 | CA1 (0.52) | CA1CA2CA9CA12CA7 | |
| SCHEMBL339191 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL16343055 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15156819 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL30865611 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL339980 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28702213 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28760005 | 0.98 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28575142 | 0.93 | MEN1 (0.52) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5604680 | 0.92 | CA1 (0.47) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3771336-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| EP-3771335-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| CN-110338193-A | Penoxsulam preparation and preparation method thereof | 湖北广富林生物制剂有限公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-101442908-B | The tick of preparation and insect repellent composition | 纳幕尔杜邦公司 | 2016-09-28 | — | — | CN | disclosed |
| US-9314021-B2 | Formulations containing insect repellent compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-20140288167-A1 | Formulations Containing Insect Repellent Compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-25 | — | — | US | disclosed |
| US-8771718-B2 | Formulated tick and insect repellent compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-07-08 | — | — | US | disclosed |
| US-8748477-B2 | Formulations containing insect repellent compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-06-10 | — | — | US | disclosed |
| EP-2627305-A2 | COMPOSITIONS AND METHODS FOR TREATING KERATIN BASED FIBERS | Coolway Inc. (US) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012051629-A2 | COMPOSITIONS AND METHODS FOR TREATING KERATIN BASED FIBERS | MANEWORX INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| CN-101442908-A | Formulated tick and insect repellent compositions | DU PONT (US) | 2009-05-27 | — | — | CN | disclosed |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | 1,4Group, Inc. | 2007-11-15 | — | — | US | disclosed |
| US-20060223878-A1 | Formulations containing insect repellent compounds | 1,4Group, Inc. | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288167-A1 | Formulations Containing Insect Repellent Compounds | CAT, HNMT, MME | CA1 1683/4885CA2 3120/4885CA9 2308/4885 |
| US-20060223878-A1 | Formulations containing insect repellent compounds | CAT, HNMT, MME | CA1 1683/4885CA2 3120/4885CA9 2308/4885 |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | MME, FNTA, ACHE | CA1 2731/4885CA2 3144/4885CA9 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.